Market News

Stay updated with the latest market trends, earnings, and economic indicators.

Showing news for:MONIFTY500Healthcare
Clear all filters
Sensex Today | Stock Market Live: GIFT Nifty indicates a firm start; Promoter to sell stake in Vedanta
positive
Moneycontrol NaNd ago

Sensex Today | Stock Market Live: GIFT Nifty indicates a firm start; Promoter to sell stake in Vedanta

Sensex Today | Stock Market LIVE Updates: The S&P 500 and the Nasdaq closed down on Monday, dragged by ​declines in the megacap technology stocks including Alphabet, while investors assessed developments in U.S.-Iran negotiations. The Dow closed higher, boosted by ‌the healthcare and industrial sectors. The Dow Jones Industrial Average rose 148.01 points, or 0.29%, to 51,712.71, the ​S&P 500 lost 27.79 points, or 0.37%, to 7,472.79 and the Nasdaq Composite lost 351.33 points, or 1.32%, to 26,166.60.

AONETMMQ50AONETOTALGROWWLOVOLGROWWMOM50HCGHCG-REHDFCGROWTHHEALTHADDHEALTHAXISHEALTHCAREHEALTHIETFHEALTHYMOCAPITALMOMENTUM50MONIFTY500MULTICAPVALUEVEDLFinancial ServicesHealthcare
Buy Granules India; target of Rs 820: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Granules India; target of Rs 820: Motilal Oswal

Motilal Oswal is bullish on Granules India has recommended buy rating on the stock with a target price of Rs 820 in its research report dated April 29, 2026.

GRANULESMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Buy Five Star Business Finance; target of Rs 600: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Five Star Business Finance; target of Rs 600: Motilal Oswal

Motilal Oswal recommended is bullish on Five Star Business Finance recommended buy rating on the stock with a target price of Rs 600 in its research report dated Jun 22, 2026.

FIVESTARLTFMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESTARFinancial ServicesHealthcare
Buy Mankind Pharma; target of Rs 2640: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Mankind Pharma; target of Rs 2640: Motilal Oswal

Motilal Oswal is bullish on Mankind Pharma has recommended buy rating on the stock with a target price of Rs 2640 in its research report dated April 29, 2026.

MANKINDMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCFinancial ServicesHealthcare
Buy Piramal Pharma; target of Rs 190: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Piramal Pharma; target of Rs 190: Motilal Oswal

Motilal Oswal is bullish on Piramal Pharma has recommended buy rating on the stock with a target price of Rs 190 in its research report dated April 29, 2026.

MOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEPPLPHARMASPARCFinancial ServicesHealthcare
Buy Star Health; target of Rs 640: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Star Health; target of Rs 640: Motilal Oswal

Motilal Oswal is bullish on Star Health has recommended buy rating on the stock with a target price of Rs 640 in its research report dated April 29, 2026.

MEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESTARSTARHEALTHFinancial ServicesHealthcare
PSL offloads 0.6% stake in Sun Pharma Advanced Research, Motilal Oswal buys additional 0.7% stake in Adisoft
positive
Moneycontrol NaNd ago

PSL offloads 0.6% stake in Sun Pharma Advanced Research, Motilal Oswal buys additional 0.7% stake in Adisoft

Sun Pharma Advanced Research Company shares fell 3.72 percent to Rs 143.04 amid high volumes

ADISOFTMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESPARCCapital GoodsFinancial Services
Buy Star Health; target of Rs 700: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Star Health; target of Rs 700: Motilal Oswal

Motilal Oswal is bullish on Star Health recommended buy rating on the stock with a target price of Rs 700 in its research report dated Jun 25, 2026.

MEDANTAMOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUESTARSTARHEALTHFinancial ServicesHealthcare
Buy Rubicon Research; target of Rs 955: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Rubicon Research; target of Rs 955: Motilal Oswal

Motilal Oswal is bullish on Rubicon Research recommended buy rating on the stock with a target price of Rs 955 in its research report dated April 15, 2026.

MOALPHA50MOBANK10MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUERUBICONFinancial ServicesHealthcare
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Laurus Labs; target of Rs 1280: Motilal Oswal

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated March 19, 2026.

LAURUSLABSMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Buy Laurus Labs; target of Rs 1280: Motilal Oswal
positive
Moneycontrol NaNd ago

Buy Laurus Labs; target of Rs 1280: Motilal Oswal

Motilal Oswal is bullish on Laurus Labs recommended buy rating on the stock with a target price of Rs 1280 in its research report dated February 25, 2026.

LAURUSLABSMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare
Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal
neutral
Moneycontrol NaNd ago

Neutral ALKEM Laboratories; target of Rs 5525: Motilal Oswal

Motilal Oswal recommended Neutral rating on ALKEM Laboratories with a target price of Rs 5525 in its research report dated February 14, 2026.

ALKEMMOALPHA50MOCAPITALMODEFENCEMOENERGYMOGOLDMOGSECMOHEALTHMOINFRAMOIPOMOLOWVOLMOM100MOM50MOMENTUM50MOMGFMOMIDMTMMOMNCMOMOMENTUMMON100MON50EQUALMONEXT50MONIFTY100MONIFTY500MONQ50MOPSEMOQUALITYMOREALTYMOSERVICEMOSILVERMOSMALL250MOTILALOFSMOTOURMOVALUEFinancial ServicesHealthcare